Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05913609

Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Miami - Jackson Memorial, Miami, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject 18 years of age or older at time of consent.
  • Subject planning on vaginal birth.
  • Singleton pregnancy in vertex presentation.
  • Full-term pregnancy having completed 37 weeks or more gestational weeks.
  • Able and willing to provide written informed consent prior to enrollment.
  • In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF).
  • Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery."

Exclusion criteria

  • Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ± suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.)
  • Cesarean section is planned for the patient.
  • Obstetric contraindications to vaginal birth.
  • Subject carrying fetus with known significant chromosomal or structural anomalies.
  • Clinically estimated fetal weight ≥5kg in non-diabetic subjects.
  • Clinically estimated fetal weight ≥4.5kg in subjects with diabetes.
  • Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy.
  • Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc.
  • Any maternal disease or disorder that precludes the subject from pushing effectively.
  • If the maternal cervix is not fully dilated.
  • If the fetal head is not completely out of the birth canal.
  • In the presence of a non-reducible nuchal cord.

Treatment and study plan

Yaari Extractor

Device

The Yaari Extractor device is a single-use prescription device for neonatal extraction in deliveries that are complicated by shoulder dystocia. The Study Device consists of two curved, rigid plastic-coated metal Arms with Handles which are used for control of the device outside the body, and an elastic Engagement Element which conforms to the maternal and neonatal anatomy, and which is used for direct contact with the entrapped neonate within the birth canal.

Primary outcomes

  1. Number of successful neonate deliveries with the Yaari Extractor device

    Time frame: immediately after the intervention

    First Primary Effectiveness Endpoint

  2. Time interval (minutes) from the diagnosis of the shoulder dystocia until the neonate's delivery

    Time frame: immediately after the intervention

    Second Primary Effectiveness Endpoint

  3. Maternal and neonatal adverse events

    Time frame: through study completion, an average of 5 days

    Primary Safety Endpoint

Secondary outcomes

  1. Ease of Use 5 point Likert scale User Questionnaire

    Time frame: immediately after the intervention

    Secondary Effectiveness Endpoint

Study contacts

Contact information is provided by the study sponsor or research team.

Ahava Stein

CONTACT

[email protected]

+972522346927

Sponsors and collaborators

Lead sponsor

FetalEase Ltd.

Industry

Registry information

Official study title

IDE Clinical Study to Evaluate the Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Jun 22, 2023
Registry last updated
Nov 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.